Lightpoint Medical
- Industry
- Medical Devices
- Founded Year
- 0
- Headquarters
- Amersham, United Kingdom
- Employee Count
- 0
Key People
- Dr. David Tuch - Founder and Executive Chair
- Graeme Smith - CEO
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The leadership team has over a decade of experience in the medical device industry.
Dr. David Tuch and Graeme Smith have significant experience in the medical device sector, contributing to the company's strategic direction and innovation.
- Clinical Need
-
Aspect: Very Strong
Summary: There is a significant unmet need for precise intra-operative cancer detection tools.
Lightpoint Medical's SENSEI probe provides real-time intra-operative detection of cancer, enhancing surgical outcomes and addressing a pressing clinical need.
- Competition
-
Aspect: First mover
Summary: Lightpoint Medical is a pioneer in miniaturized intra-operative cancer detection tools.
The company's innovative approach and early market entry position it ahead of potential competitors in the intra-operative cancer detection space.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing miniaturized imaging tools presents moderate technical challenges.
While the technology is innovative, miniaturization and integration with existing surgical systems require overcoming moderate technical hurdles.
- Patent
-
Aspect: Strong
Summary: The company holds strong patents protecting its technology.
Lightpoint Medical's patents safeguard its proprietary technology, providing a competitive edge and potential for licensing opportunities.
- Financing
-
Aspect: Strategics
Summary: The company has secured strategic financing through acquisition.
The acquisition by Telix Pharmaceuticals in November 2023 offers significant financial resources and strategic alignment, supporting product development and market expansion.
- Regulatory
-
Aspect: 510k/PMA
Summary: The company's products have obtained necessary regulatory approvals.
SENSEI has received FDA clearance and CE Mark, enabling its use in the U.S. and Europe, which is crucial for commercialization and clinical adoption.
Opportunity Rollup
- Odds of Success
- 4.25
- Peak Market Share
- 6.45
- Segment CAGR
- 2.9%
- Market Segment
- Diagnostic Imaging
- Market Sub Segment
- Intra-operative Imaging Devices
Year Post Launch | Market Penetration (%) |
---|---|
1 | 0.32 |
2 | 0.97 |
3 | 2.26 |
4 | 4.52 |
5 | 6.45 |
Key Takeaway
Lightpoint Medical's innovative intra-operative imaging solutions, bolstered by strategic acquisition, position it strongly in the growing precision surgery market.